Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae:: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003)
被引:30
作者:
DiPersio, JR
论文数: 0引用数: 0
h-index: 0
机构:JIM Labs, JONES Grp, N Liberty, IA 52317 USA
DiPersio, JR
Deshpande, LM
论文数: 0引用数: 0
h-index: 0
机构:JIM Labs, JONES Grp, N Liberty, IA 52317 USA
Deshpande, LM
Biedenbach, DJ
论文数: 0引用数: 0
h-index: 0
机构:
JIM Labs, JONES Grp, N Liberty, IA 52317 USAJIM Labs, JONES Grp, N Liberty, IA 52317 USA
During 2001, occurrences of extended-spectrum beta-lactamase (ESBL) -producing Klebsiella pneunioniae isolates were detected in a single medical center (Hospital A) from the SENTRY Antimicrobial Surveillance Program that became endemic in long-term acute care areas and in the intensive care unit in 2002-2003. Between 2001 and 2003, 123 patients were infected or colonized with ESBL-positive K. pneumoniae. Resistance profiles were determined by reference broth microdilution methods, and automated ribotyping and pulsed-field gel electrophoresis (PFGE) were performed. The ESBL-positive K. pneumoniae isolates were resistant to aztreonam, ceftazidime, aminoglycosides, and trimethoptim/sulfamethoxazole and susceptible to ciprofloxacin and tetracycline. In 1997, 1998, and 2000, 9 ESBL-producing,&.'. pneumoniae strains from 2 New York City hospitals shared the same antibiograms and ribotype (204.2) as the strains from Hospital A. PFGE patterns divided Hospital A isolates into 2 subtypes (A and A,) and 3 New York City strains were similar to the Hospital A isolates (A(2), A(3), and A(4))Isoelectric focusing studies of I New York City isolate (A4) revealed pIs at 5.4, 7.7, and 8.2. PCR and sequencing results from I strain of each Hospital A and I New York PFGE pattern determined that TEM-1 and SHV-5 (ESBL) were present in all strains. In addition, 2 New York isolates from 1998 (A3 and A4) also had an OXA-2 enzyme. ESBL-producing K. pneumoniae isolates with ribotype 204.2 from SENTRY Program sites have been recognized in New York only since 1997 and in Hospital A beginning in 2001. The similarities of the antibiogram and epidemiological patterns suggest that these isolates have persisted over time and may have evolved into different but genetically related endemic ESBL-positive K. pneunmoniae clones that have the ability to cause sustained epidemic outbreaks in US medical centers. (C) 2005 Published by Elsevier Inc.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 34 条
[1]
[Anonymous], 2003, NCCLS Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, V6th
机构:
UNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCEUNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCE
BILLOTKLEIN, D
GUTMANN, L
论文数: 0引用数: 0
h-index: 0
机构:
UNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCEUNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCE
GUTMANN, L
COLLATZ, E
论文数: 0引用数: 0
h-index: 0
机构:
UNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCEUNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCE
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Edelstein, M
Pimkin, M
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Pimkin, M
Palagin, I
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Palagin, I
Edelstein, I
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Edelstein, I
Stratchounski, L
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
机构:
UNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCEUNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCE
BILLOTKLEIN, D
GUTMANN, L
论文数: 0引用数: 0
h-index: 0
机构:
UNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCEUNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCE
GUTMANN, L
COLLATZ, E
论文数: 0引用数: 0
h-index: 0
机构:
UNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCEUNIV PARIS 06, MICROBIOL MED LAB, 15 RUE ECOLE MED, F-75270 PARIS 06, FRANCE
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Edelstein, M
Pimkin, M
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Pimkin, M
Palagin, I
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Palagin, I
Edelstein, I
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia
Edelstein, I
Stratchounski, L
论文数: 0引用数: 0
h-index: 0
机构:
Smolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, RussiaSmolensk State Med Acad, Inst Antimicrobial Chemotherapy, Smolensk 214019, Russia